Unknown OBSERVATIONAL NCT00671346

NORVIT and WENBIT - Long-term Follow-up (NORVITWENBIT)

Combined Analyses and Long-term Follow-up in the Two Norwegian Homocysteine-Lowering B-Vitamin Trials NORVIT and WENBIT

Sponsor: Haukeland University Hospital

Conditions Cancer Cerebrovascular Stroke Myocardial Infarction

Updated 7 times since 2017 Last updated: Nov 4, 2015 Started: Dec 31, 1998 Primary completion: Dec 31, 2020 Completion: Jan 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cancer and Cerebrovascular Stroke and is currently ongoing. Haukeland University Hospital leads this study, which shows 7 recorded versions since 1998 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2021 — Jul 2024 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Feb 2021 [monthly]

Active Not Recruiting
Jun 2018 — Jan 2021 [monthly]

Active Not Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

First recorded

Dec 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Haukeland University Hospital
Norwegian Foundation for Health and Rehabilitation
University of Tromso

Data source: Haukeland University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bergen, Norway
• Tromsø, Norway